spacer
home > pmps > summer 2017 > the patient is the key
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

The Patient is the Key

The Parenteral Drug Association’s (PDA’s) conference theme this year will be ‘Improving Patient Outcomes with Innovative Drug Delivery’. With more biologics developed to treat chronic diseases, this title reflects the everincreasing commitment to enhancing the self-injecting experience and improving patient outcomes.

This event aspires to educate attendees on global trends, providing a future outlook on all aspects surrounding pre-filled syringes and injection devices. It will highlight links in the manufacturing chain – from materials and component industries to clinical and patient needs. One focus will be on the overall biotechology sector, while also looking closely at largevolume applications, formulations and biosimilars and advanced therapeutic products.

Three parallel tracks will discuss new uses, challenges and opportunities of patient-to-smart device interactions as they become more significant and sophisticated, thus having an immediate positive effect on patient adherence and therapy outcomes. Questions such as: ‘How can learnings and findings from clinical trials and usability work be incorporated into more patient-friendly delivery systems?’ will be posed and debated.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer

Print this page
Send to a friend
Privacy statement
News and Press Releases

York Health Economics Consortium offers a new health utilities training course

Cost-utility analysis is a requirement for NICE health technology appraisals and is being increasingly used in other contexts and countries. Health utilities, a crucial component of cost-utility analysis, capture the relative change in health-related quality of life resulting from a treatment. As such, health utility can be a key driver of the cost-effectiveness ratio. Obtaining health utility values that are suitable for your economic evaluation, however, may not always be straight forward.
More info >>

White Papers

PhlexEview: Transforming Costly Paper Processes into Value Driven Compliance

Phlexglobal Ltd

Looking at some of the challenges of traditional paper-based Trial Master Files (TMFs), and how they can be overcome with Phlexglobal's best in breed electronic TMF system, PhlexEview.
More info >>

 
Industry Events

TAT 2018 – Targeted Anticancer Therapies

5-7 March 2018, Paris Marriott Rive Gauche Hotel & Conference Centre

The constant evolution of early phase development and translational research drove ESMO to enrich its meeting portfolio by acquiring the TAT Congress and providing a discussion platform focusing on new molecular targets and innovative cancer therapeutics.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement